Not applicableLooking for participantsNCT04689750What this trial is testingDonor CHIP and Allogeneic HSCT OutcomeWho this might be right forClonal Hematopoiesis The University of Hong Kong 850
Not applicableLooking for participantsNCT06870760What this trial is testingPre-malignant States to Hematologic Malignancies in FirefightersWho this might be right forClonal Hematopoiesis of Indeterminate PotentialMonoclonal GammopathyNon Hodgkin Lymphoma+3 more Wake Forest University Health Sciences 300
Not applicableUnknownNCT05246813What this trial is testingMetabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)Who this might be right forOsteoporosisOsteoarthritis, HipHip Fractures+2 more Imelda Hospital, Bonheiden 24
Not applicableStudy completedNCT04987268What this trial is testingCHIP and Residual Cardiovascular Event Tendency After Smoking CessationWho this might be right forACSClonal Hematopoiesis of Indeterminate PotentialSmoking Cessation Shenyang Northern Hospital 1,029
Post-approval studies (Phase 4)Not Yet RecruitingNCT07362966What this trial is testingEffect of Colchicine on Progression of Coronary Atherosclerosis in Patients With TET2-CHIP VariantWho this might be right forColchicineCoronary Atherosclerosis ManagementClonal Hematopoiesis of Indeterminate Potential Shenyang Northern Hospital 120
Not applicableLooking for participantsNCT04102423What this trial is testingCHIP/CCUS Natural History ProtocolWho this might be right forClonal Hematopoiesis of Indeterminate PotentialClonal Cytopenia of Undetermined Significance National Heart, Lung, and Blood Institute (NHLBI) 306
Not applicableLooking for participantsNCT04053439What this trial is testingClonal Hematopoiesis is a Risk Factor for Chemotherapy-Related ComplicationsWho this might be right forLymphomaChemotherapeutic Toxicity Sunnybrook Health Sciences Centre 188
Not applicableLooking for participantsNCT06785077What this trial is testingGenetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP InhibitorsWho this might be right forLeukemia, Myeloid, AcuteMyeloid DysplasiaOvarian Epithelial Cancer European Institute of Oncology 157
Testing effectiveness (Phase 2)Study completedNCT06097663What this trial is testingInvestigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)Who this might be right forCoronary Heart DiseaseClonal Hematopoiesis of Indeterminate Potential (CHIP) Novartis Pharmaceuticals 31
Not applicableUnknownNCT05828888What this trial is testingCHIP in Endothelial Dysfunction Associated With HEpEFWho this might be right forHeart Failure With Preserved Ejection Fraction University Hospital, Bordeaux 80